申请人:The Board of Trustees of the University of Illinois
公开号:US10285986B2
公开(公告)日:2019-05-14
Compositions comprising Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compositions are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.
由式(I)组成的组合物可对多种不同类型的癌细胞产生选择性杀伤作用。这些组合物可用于疾病的管理、治疗、控制或辅助治疗,其中选择性致死在化疗中是有益的。